Efavirenz
Drug Details
- Description
- Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretroviral agents for the treatment of HIV-1 infection. It works by inhibiting the activity of reverse transcriptase, a viral enzyme necessary for viral replication.
- Alternative Names
- Efavirenz (EFV)
- Key Genes
- Key genes for Efavirenz include CYP2B6, CYP3A4, and CYP2A6. These genes are involved in its metabolism and can affect drug levels and side effects.
- Drug Use
- Efavirenz is an antiretroviral drug used in the treatment of HIV infection. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is often used in combination with other antiretroviral medications to suppress the viral load and increase CD4 cell counts in HIV patients.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report